Operating Lease, Right-of-Use Asset of iBio, Inc. from 30 Jun 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
iBio, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Jun 2021 to 30 Sep 2025.
  • iBio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,958,000, a 4.5% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

iBio, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,958,000 -$93,000 -4.5% 30 Sep 2025 10-Q/A 17 Nov 2025 2026 Q1
Q2 2025 $2,051,000 -$350,000 -15% 30 Jun 2025 10-Q/A 17 Nov 2025 2026 Q1
Q1 2025 $2,142,000 -$330,000 -13% 31 Mar 2025 10-Q 02 May 2025 2025 Q3
Q4 2024 $2,230,000 -$335,000 -13% 31 Dec 2024 10-Q 10 Feb 2025 2025 Q2
Q3 2024 $2,051,000 -$594,000 -22% 30 Sep 2024 10-Q/A 17 Nov 2025 2026 Q1
Q2 2024 $2,401,000 -$321,000 -12% 30 Jun 2024 10-K 05 Sep 2025 2025 FY
Q1 2024 $2,472,000 -$314,000 -11% 31 Mar 2024 10-Q 13 May 2024 2024 Q3
Q4 2023 $2,565,000 -$308,000 -11% 31 Dec 2023 10-Q 09 Feb 2024 2024 Q2
Q3 2023 $2,645,000 -$283,000 -9.7% 30 Sep 2023 10-Q 14 Nov 2023 2024 Q1
Q2 2023 $2,722,000 -$346,000 -11% 30 Jun 2023 10-K/A 24 Sep 2024 2024 FY
Q1 2023 $2,786,000 -$2,365,000 -46% 31 Mar 2023 10-Q 15 May 2023 2023 Q3
Q4 2022 $2,873,000 -$2,418,000 -46% 31 Dec 2022 10-Q/A 19 May 2023 2023 Q2
Q3 2022 $2,928,000 -$559,000 -16% 30 Sep 2022 10-Q 14 Nov 2022 2023 Q1
Q2 2022 $3,068,000 +$3,068,000 30 Jun 2022 10-K 27 Sep 2023 2023 FY
Q1 2022 $5,151,000 31 Mar 2022 10-Q 12 May 2022 2022 Q3
Q4 2021 $5,291,000 31 Dec 2021 10-Q 14 Feb 2022 2022 Q2
Q3 2021 $3,487,000 30 Sep 2021 10-Q 15 Nov 2021 2022 Q1
Q2 2021 $0 30 Jun 2021 10-Q 12 May 2022 2022 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.